Myeloid OTULIN deficiency couples RIPK3-dependent cell death to Nlrp3 inflammasome activation and IL-1β secretion

M Giulia Doglio1,2, Lien Verboom2,3, Emily Ruilova Sosoranga1,2

  • 1Department of Internal Medicine and Paediatrics, Ghent University, 9052 Ghent, Belgium.

Science Immunology
|November 24, 2023
PubMed

Insights

Loss-of-function mutations in OTULIN cause autoinflammatory syndrome. OTULIN deficiency triggers RIPK3-mediated cell death, activating the Nlrp3 inflammasome and IL-1β release in macrophages.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Loss-of-function mutations in the deubiquitinase OTULIN cause OTULIN-related autoinflammatory syndrome (ORAS).
  • OTULIN is crucial for inflammatory and cell death signaling, but its precise role in linking cell death to inflammation is unknown.

Purpose of the Study:

  • To elucidate the mechanisms by which OTULIN deficiency connects cell death to inflammation.
  • To identify the role of OTULIN in regulating RIPK3-mediated cell death and Nlrp3 inflammasome activation.

Main Methods:

  • Utilizing genetic mouse models with myeloid-specific OTULIN deficiency.
  • Investigating the activation of the Nlrp3 inflammasome and IL-1β secretion.
  • Analyzing the interplay between OTULIN, RIPK3, and gasdermin D in macrophage cell death.

Main Results:

  • OTULIN deficiency licenses RIPK3-mediated cell death in murine macrophages.
  • This RIPK3-dependent cell death activates the Nlrp3 inflammasome, leading to IL-1β secretion.
  • OTULIN deficiency uncoupled Nlrp3 inflammasome activation from gasdermin D-mediated pyroptosis.

Conclusions:

  • OTULIN acts as an inhibitor of RIPK3-mediated IL-1β release in mice.
  • OTULIN deficiency promotes inflammation by linking RIPK3-dependent cell death to Nlrp3 inflammasome activation.
  • Targeting OTULIN may offer therapeutic strategies for inflammatory diseases.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K